T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
15,112,162
Share change
-3,980,945
Total reported value
$7,916,692
Put/Call ratio
61%
Price per share
$0.52
Number of holders
62
Value change
-$2,084,937
Number of buys
13
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q1 2022

As of 31 Mar 2022, T2 BIOSYSTEMS INC - COM (TTOO) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,112,162 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GAGNON SECURITIES LLC, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, FRANKLIN RESOURCES INC, CITADEL ADVISORS LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP. This page lists 62 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.